SARILUMAB FOR THE TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: RESULTS OF A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, INTERNATIONAL STUDY

被引：0
|
作者：
Huizinga, T. W. [1 ]
Kivitz, A. J. [2 ]
Rell-Bakalarska, M. [3 ]
Fleischmann, R. M. [4 ]
Jasson, M. [5 ]
Radin, A. R. [6 ]
Genovese, M. C. [7 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[2] Altoona Ctr Clin Res, Dept Rheumatol, Duncansville, PA USA
[3] Rheumatol & Osteoporosis Outpatient Clin, Warsaw, Poland
[4] 1 Metroplex Clin Res Ctr, Dallas, TX USA
[5] Sanofi, Paris, France
[6] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
[7] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.1706
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [41] Results from a randomized, double-blind, placebo-controlled, exploratory, multicenter study of GBR 830 in adult patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Pavel, Ana B.
    Estrada, Yeriel
    Zhang, Ning
    Peng, Xiangyu
    Xu, Hui
    Wen, Huei-Chi
    Fang, Hui
    Salhi, Yacine
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB245 - AB245
  • [42] Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial
    Khatereh Sepanjnia
    Amirhossein Modabbernia
    Mandana Ashrafi
    Mohammad-Jafar Modabbernia
    Shahin Akhondzadeh
    Neuropsychopharmacology, 2012, 37 : 2093 - 2100
  • [43] Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety
    Lai, Vivien Wai Yun
    Chen, Gang
    Gin, Douglas
    Sinclair, Rodney
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (03) : 694 - 701
  • [44] Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial
    Sepanjnia, Khatereh
    Modabbernia, Amirhossein
    Ashrafi, Mandana
    Modabbernia, Mohammad-Jafar
    Akhondzadeh, Shahin
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (09) : 2093 - 2100
  • [45] DOCOSAHEXAENOIC ACID TREATMENT OF RHEUMATOID ARTHRITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY
    Neumann, T.
    Dawczynski, C.
    Dittrich, M.
    Goetze, K.
    Welzel, A.
    Oelzner, P.
    Voelker, S.
    Schaible, A. M.
    Troisi, F.
    Thomas, L.
    Pace, S.
    Koeberle, A.
    Werz, O.
    Schlattmann, P.
    Lorkowski, S.
    Jahreis, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 115 - 115
  • [46] Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial
    Salardini, Elaheh
    Zeinoddini, Atefeh
    Mohammadinejad, Payam
    Khodaie-Ardakani, Mohammad-Reza
    Zahraei, Nagmeh
    Zeinoddini, Arefeh
    Akhondzadeh, Shahin
    JOURNAL OF PSYCHIATRIC RESEARCH, 2016, 75 : 24 - 30
  • [47] Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study
    Buondonno, Ilaria
    Rovera, Guido
    Sassi, Francesca
    Rigoni, Micol Maria
    Lomater, Claudia
    Parisi, Simone
    Pellerito, Raffaele
    Isaia, Giovanni Carlo
    D'Amelio, Patrizia
    PLOS ONE, 2017, 12 (06):
  • [48] Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study
    Gebauer, Kurt
    Spelman, Lynda
    Yamauchi, Paul S.
    Bagel, Jerry
    Nishandar, Tushar
    Crane, Michael
    Kopeloff, Iris
    Kothekar, Mudgal
    Yao, Siu-Long
    Sofen, Howard L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (01) : 91 - 99
  • [49] Randomised, Placebo-Controlled, Double-Blind Study of Oral Tranexamic Acid in the Treatment of Moderate-to-Severe Melasma in an Australian Cohort
    Bala, Harini Rajgopal
    Nguyen, Jennifer
    Ross, Angelique
    Wong, Celestine
    Paul, Eldho
    Rodrigues, Michelle
    INDIAN JOURNAL OF DERMATOLOGY, 2022, 67 (04) : 454 - 458
  • [50] Efficacy and safety of adalimumab in treatment of moderate to severe hidradenitis suppurativa: Results from the placebo-controlled portion of a phase II, randomized, double-blind study
    Kimball, A.
    Jemec, G.
    Okun, M.
    Gu, Y.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB155 - AB155
12345